Levophed and Cardiogenic shock - a phase IV clinical study of FDA data

Summary:

Cardiogenic shock is reported as a side effect among people who take Levophed (norepinephrine bitartrate), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Lasix, and have Pulmonary embolism.

The phase IV clinical study analyzes which people have Cardiogenic shock when taking Levophed. It is created by eHealthMe based on reports of 2,040 people who have side effects when taking Levophed from the FDA, and is updated regularly.

What is Levophed?

Levophed has active ingredients of norepinephrine bitartrate. eHealthMe is studying from 2,047 Levophed users. Check the latest studies of Levophed.

What is Cardiogenic shock?

Cardiogenic shock (inadequate circulation of blood) is found to be associated with 928 drugs and 1,159 conditions by eHealthMe. Check the latest studies of Cardiogenic shock.

On Jul, 12, 2026

2,040 people reported to have side effects when taking Levophed.
Among them, 95 people (4.66%) have Cardiogenic shock.

Among these 95 people:

How long have people been on Levophed when they have Cardiogenic shock? *

What is the gender of people who have Cardiogenic shock when taking Levophed? *

female: 51.09 %
male: 48.91 %

What is the age of people who have Cardiogenic shock when taking Levophed? *

What are other drugs people take besides Levophed? *

What are other side effects people have besides Cardiogenic shock? *

Acute Kidney Failure: 35 people, 36.84%
Stress And Anxiety: 34 people, 35.79%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 23 people, 24.21%
High Blood Cholesterol: 23 people, 24.21%
Nausea And Vomiting: 23 people, 24.21%
Death: 22 people, 23.16%
Sepsis (a severe blood infection that can lead to organ failure and death): 22 people, 23.16%
Ventricular Fibrillation (abnormally irregular heart rhythm): 21 people, 22.11%
Cardiac Failure Congestive: 20 people, 21.05%
Abdominal Distension: 20 people, 21.05%

What are the existing conditions these people have? *

Pulmonary Embolism (blockage of the main artery of the lung): 21 people, 22.11%
Sleep Disorder: 19 people, 20.00%
Stress And Anxiety: 18 people, 18.95%
Nausea And Vomiting: 18 people, 18.95%
Diabetes: 17 people, 17.89%
Thrombosis (formation of a blood clot inside a blood vessel): 16 people, 16.84%
Dyspnea (difficult or laboured breathing): 16 people, 16.84%
Bacterial Infection: 16 people, 16.84%
Anaemia (lack of blood): 16 people, 16.84%
Constipation: 16 people, 16.84%

* Approximation only. Some reports may have incomplete information.

Do you take Levophed and have Cardiogenic shock?

- Check whether Cardiogenic shock is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Levophed:

Levophed (2,047 reports)

Browse all side effects of Levophed:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Cardiogenic shock:

Cardiogenic shock (928 drugs)

Browse all the conditions that are associated with Cardiogenic shock:

Cardiogenic shock (1,159 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on norepinephrine bitartrate (the active ingredients of Levophed) and Levophed (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.